HUYABIO International Unveils Positive Results from HBI-3000 Phase 2A Clinical Trial for Acute Atrial Fibrillation Discover how HUYABIO International's HBI-3000 offers promising clinical results for atrial fibrillation treatment, enhancing patient care.

HUYABIO International Unveils Positive Results from HBI-3000 Phase 2A Clinical Trial for Acute Atrial Fibrillation #United_States #San_Diego #Atrial_Fibrillation #HUYABIO #HBI-3000

HUYABIO International Welcomes Paul Spreen as Chief Business Officer to Enhance Global Strategy HUYABIO International is thrilled to announce Paul Spreen's new role as Chief Business Officer, bringing vital expertise for global development.

HUYABIO International Welcomes Paul Spreen as Chief Business Officer to Enhance Global Strategy #USA #San_Diego #Biopharmaceutical #HUYABIO #Paul_Spreen